MedTrace Logo

Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden

NCT02963675 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15953

Last updated 2018-02-12

No results posted yet for this study

Summary

This study is conducted to obtain information about prostate cancer patients with bone metastases before the end of 2013. The incidence of second primary malignancies and overall survival in patients with castration resistant prostate cancer are of particular interest. Information from this study will serve as a historical reference for the REASSURE study (Background incidence study)

Conditions

  • Prostatic Neoplasms

Interventions

OTHER

external unexposed reference group

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-15
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Sweden

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02963675 on ClinicalTrials.gov